Description
Glucolipid Metabolic Disease (GMD) is an innovative journal that presents peer-reviewed clinical and scientific research on the identification, prevention, control, and treatment of glucolipid metabolic diseases (GLMD). Due to lifestyle changes in recent years, this chronic disorder has resulted in an economic burden to healthcare systems around the world and poses a significant problem for public health. The ongoing prevalence of such metabolic diseases, with links to diabetes and obesity, indicates that current prevention and treatment methods are not working. Thus, it is imperative that finding new strategies to mitigate GLMD be undertaken by the world’s foremost experts.
Glucolipid Metabolic Disease (GMD) publishes these efforts through leading research articles, commentaries, and reviews that discuss all aspects of GLMD as well as its correlation with other risk factors such as cardiovascular diseases and neurological disorders. Crucially, the journal welcomes both Eastern and Western medical approaches, and a combination of thereof, to introduce groundbreaking prevention and treatment theory, pathogenesis, treatment strategy, drug research, and health management of metabolic diseases. This journal is vital for doctors, nutritionists, medical personnel, researchers, academicians, and students seeking the most up-to-date practices in this new field of medicine.
Editorial Review Board
Editorial Board is currently being developed.